Blog

CPHI Milan 2026: The Future of Pharmaceutical Manufacturing and Key Priorities Ahead

As the global pharma community comes together at CPHI Milan 2026, these priorities will help shape discussions not simply about where pharmaceutical manufacturing is heading, but how companies intend to get there.

Improving Oral Bioavailability Through Nanotechnology-Based Oral Formulations

Nanotechnology is expanding the options available to formulation scientists for addressing some of these limitations. Nano-enabled drug delivery systems, including nanocrystals, lipid nanoparticles and polymeric nanoparticles, can alter how poorly soluble APIs disperse, dissolve, or remain protected within the gastrointestinal environment.

Orodispersible Tablets vs. Orodispersible Films

Orodispersible tablets (ODTs) and orodispersible films (ODFs) address this limitation through dosage forms designed to disintegrate in the oral cavity without requiring water. However, they are not interchangeable platforms.

DC Granules Manufacturers in India: Applications, Benefits, and Manufacturing Expertise

As pharmaceutical companies continue to prioritise faster product development, cost efficiency, and manufacturing scalability, directly compressible (DC) granules have become an increasingly important part of solid oral dosage manufacturing.

Pharmaceutical Taste Masking: A Broad Overview of Its Role in Patient-Centric Drug Delivery

Pharmaceutical taste masking has therefore evolved from a formulation refinement into a fundamental requirement in modern oral drug delivery, particularly for patient populations that are highly sensitive to bitterness. to bitterness.

A Complete Guide to Nutraceuticals in Preventive Health and Chronic Care Support

Preventive healthcare focuses on identifying and managing health risks before they progress into chronic disease. Within this approach, nutraceutical supplements are increasingly being incorporated into broader wellness strategies because they contain bioactive ingredients that help support normal physiological function, metabolic balance, immune health, and cellular protection.

New Frontiers in Taste Masking Technology for Oral Drug Delivery

Oral dosage forms are evolving. Oral thin films, orally disintegrating systems, multiparticulates, and personalised medicines are becoming more prevalent. Formulation scientists must address taste without compromising dissolution, stability, bioavailability, or therapeutic performance.

Personalised Medicine and the Future of Patient-Centric Drug Delivery

The pharmaceutical industry is moving beyond broad population-based therapies toward increasingly targeted treatment strategies. Advances in genomics, biomarker-driven drug development, and precision diagnostics are enabling therapies designed for narrower patient groups with more defined clinical profiles.

How ESG Is Influencing Pharmaceutical Manufacturing Across Global Markets

As sustainability expectations become more deeply embedded into global sourcing frameworks, pharmaceutical manufacturers are increasingly recognising ESG as a business priority rather than a standalone compliance exercise.

The Future of Oral Drug Delivery Systems in India: A Nano-Driven Shift

Nanotechnology-based oral drug delivery addresses these limitations by engineering drug carriers at the nanometre scale, typically between 1 and 100 nanometres. This significantly increases surface area and improves dissolution behaviour, allowing better absorption and enhanced therapeutic efficiency.

7-9% Growth Projection: A Strategic Roadmap to Pharmaceutical Manufacturing in 2026

India’s pharmaceutical sector enters 2026 with momentum built over several years. Post-pandemic recovery has stabilised supply chains, restored export flows, and reinforced India’s role as a dependable supplier of affordable medicines.

From Niche to Industrial Scale: The Evolving Role of Oral Thin Film Manufacturers

Oral thin film manufacturing involves the production of thin polymer-based films designed to dissolve rapidly in the oral cavity. These films deliver APIs through buccal or sublingual pathways depending on formulation design and therapeutic intent.

Nutraceuticals in Oral Disintegrating Strips: The Next Frontier in Functional Wellness

Nutraceuticals in oral disintegrating strips are thin-film dosage systems designed to dissolve rapidly when placed on the tongue or oral mucosa. These strips deliver functional ingredients such as vitamins, minerals, botanicals, and other bioactive compounds through a convenient oral format.

Preventive Healthcare and the Pharma Industry: Unlock New Growth Opportunities

Healthcare systems globally are under sustained pressure from rising cases of diabetes, cardiovascular disorders, respiratory conditions, and other chronic illnesses. This has led to a structural shift in how healthcare is delivered.

Capsules vs Oral Thin Films for Gut Health: A Supplements Manufacturer’s Guide

A pharmaceutical manufacturer working in the nutraceutical space plays a critical role in translating formulation intent into a viable product.

The Lifecycle of a Pharmaceutical Product in Contract Manufacturing

The pharmaceutical product lifecycle spans from early discovery to commercial supply and post-market management. The key five stages include API development, pre-formulation, formulation development, manufacturing, and distribution.

How Manufacturers of Supplements Support Urology Portfolios

Nutraceutical supplement manufacturers advanced R&D and formulation capabilities to create multi-ingredient, high-bioavailability supplements, integrating cutting-edge delivery technologies without compromising efficacy.

Capabilities That Define Leading Pellets Manufacturers in India

Pellets in pharmacy are widely used for modified and controlled release applications, allowing precise modulation of drug release profiles and more consistent therapeutic outcomes. Their multiparticulate nature ensures uniform distribution in the gastrointestinal tract, which supports predictable absorption across patient populations.

difference between api and formulation in pharma

Pharmaceutical Formulation Intermediates vs APIs: Key Differences and How to Choose

A Pharmaceutical Formulation Intermediate (or PFI) is a blend of active substances and excipients, oftentimes in a powdered form. An Active Pharmaceutical Ingredient (or API), on the other hand, is the active component of the drug that acts on the symptoms of a disease.

Formulation Aspects of Sublingual Tablets

In today’s fast-paced world, people demand medications that act swiftly and effectively. Sublingual technology or tablets have become a key solution, offering a rapid onset of action that is crucial for managing various medical conditions.